CPR Invest Medtech U EUR

The investment objective is to outperform global equity markets over the recommended holding period (at least five years) by investing in international equities of companies involved in the medical technology ecosystem. To achieve this, the Compartment aims to select equities of companies with the best financial perspectives within a universe of companies involved in the medical technology ecosystem through sector such as diagnostics, surgery, medical monitoring, disease prevention, treatment. The Compartment equity exposure will be between 75% and 120% of its assets. The Compartment is invested for at least 75% of its assets in equity and equity equivalent securities of any country without constraints of capitalisation. Among this proportion of 75% of its assets, the Compartment may invest in China A shares via Stock Connect within a maximum of 25% of its assets. Derivative instruments will be used for hedging, arbitrage, exposure purposes and/or efficient portfolio management. The Compartment is actively managed. The Compartment may use a Benchmark a posteriori as an indicator for assessing the Compartment's performance and, as regards the performance fee benchmark used by relevant share classes, for calculating the performance fees. There are no constraints relative to any such Benchmark restraining portfolio construction. The Compartment is a financial product that promotes ESG characteristics pursuant to Article 8 of the Disclosure Regulation. The Compartment integrates Sustainability Factors in its investment process as outlined in more detail in section 4.9 "Overview of the Responsible Investment Policy" of the Prospectus.

PIR compliant

No

PEA compliant

No

PEA-PME compliant

No